{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:54:06Z","timestamp":1793876046999,"version":"4.7.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T00:00:00Z","timestamp":1687651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.vaccine.2023.06.073","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:46:01Z","timestamp":1689090361000},"page":"5159-5181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2122-0366","authenticated-orcid":false,"given":"Jamie","family":"Minchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin H.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasha","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-9459","authenticated-orcid":false,"given":"Emily R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.vaccine.2023.06.073_b0005","doi-asserted-by":"crossref","first-page":"e002502","DOI":"10.1136\/bmjgh-2020-002502","article-title":"An analysis of International Health Regulations Emergency Committees and Public Health Emergency of International Concern Designations","volume":"5","author":"Mullen","year":"2020","journal-title":"BMJ Glob Health"},{"key":"10.1016\/j.vaccine.2023.06.073_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2020.12.074","article-title":"The need for inclusion of pregnant women in COVID-19 vaccine trials","author":"Beigi","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.073_b0015","article-title":"Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response","author":"Krubiner","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.073_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.vaccine.2019.01.011","article-title":"Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response","volume":"39","author":"Krubiner","year":"2021","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2023.06.073_b0025","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1016\/j.vaccine.2016.07.032","article-title":"Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant women","volume":"34","author":"Jones","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.073_b0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/vaccines6040081","article-title":"Clinical trials and administration of Zika virus vaccine in pregnant women: Lessons (that Should Have Been) learned from excluding immunization with the Ebola vaccine during pregnancy and lactation","volume":"6","author":"Schwartz","year":"2018","journal-title":"Vaccines Basel"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.073_b0035","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0b013e3182a9ca67","article-title":"Exclusion of pregnant women from industry-sponsored clinical trials","volume":"122","author":"Shields","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.06.073_b0040","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12978-017-0430-2","article-title":"Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials","volume":"14","author":"Gomes","year":"2017","journal-title":"Reprod Health"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.073_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3138\/ijfab.1.2.5","article-title":"The second wave: toward responsible inclusion of pregnant women in research","volume":"1","author":"Lyerly","year":"2008","journal-title":"Int J Fem Approaches Bioeth"},{"key":"10.1016\/j.vaccine.2023.06.073_b0050","unstructured":"WHO. WHO recommendations on antenatal care for a positive pregnancy experience. World Health Organization; 2016. Available: https:\/\/www.who.int\/publications-detail-redirect\/9789241549912 [accessed: Apr. 10, 2021]."},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.073_b0055","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/21645515.2015.1127485","article-title":"Vaccines in pregnancy: The dual benefit for pregnant women and infants","volume":"12","author":"Marshall","year":"2016","journal-title":"Hum Vaccines Immunother"},{"issue":"24","key":"10.1016\/j.vaccine.2023.06.073_b0060","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMp1003462","article-title":"Enrolling pregnant women in research \u2014 lessons from the H1N1 influenza pandemic","volume":"362","author":"Goldkind","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.073_b0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1080\/13552074.2019.1615288","article-title":"Overcoming the \u2018tyranny of the urgent\u2019: integrating gender into disease outbreak preparedness and response","volume":"27","author":"Smith","year":"2019","journal-title":"Gend Dev"},{"key":"10.1016\/j.vaccine.2023.06.073_b0070","unstructured":"WHO. Gender equity in the health workforce: an analysis of 104 countries. World Health Organization, 1, Mar. 2019. Available: https:\/\/www.who.int\/hrh\/resources\/gender_equity-health_workforce_analysis\/en\/ [accessed: Oct. 13, 2020]."},{"issue":"7826","key":"10.1016\/j.vaccine.2023.06.073_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-020-02684-9","article-title":"Who gets a COVID vaccine first? Access plans are taking shape","volume":"585","author":"Subbaraman","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.06.073_b0080","unstructured":"NIH U.S. National Library of Medicine, \u201cClinicalTrials.gov,\u201d ClinicalTrials.gov; 2021. https:\/\/www.clinicaltrials.gov\/ [accessed Dec. 31, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0085","unstructured":"PACTR. PACTR Pan African Clinical Trials Registry. PACTR Pan African Clinical Trials Registry; 2021. https:\/\/pactr.samrc.ac.za\/ [accessed Dec. 31, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0090","unstructured":"ANZCTR. ANZCTR Australian and New Zealand Clinical Trials Registry. ANZCTR Australian and New Zealand Clinical Trials Registry; 2021. http:\/\/www.anzctr.org.au\/ [accessed Dec. 31, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0095","unstructured":"WHO. Primary registries in the WHO registry network. World Health Organization; 2021. https:\/\/www.who.int\/clinical-trials-registry-platform\/network\/primary-registries [accessed Dec. 31, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0100","unstructured":"NIH U.S. National Library of Medicine. Results Data Element Definitions for Interventional and Observational Studies. ClinicialTrials.gov; Feb. 01, 2021. https:\/\/prsinfo.clinicaltrials.gov\/results_definitions.html [accessed Feb. 19, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0105","doi-asserted-by":"crossref","first-page":"6563","DOI":"10.1016\/j.vaccine.2017.01.047","article-title":"Spontaneous abortion and ectopic pregnancy: case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data","author":"Rouse","year":"2017","journal-title":"Vaccine 35(48Part A)"},{"key":"10.1016\/j.vaccine.2023.06.073_b0110","unstructured":"National Institutes of Health. Preterm Labor and Birth. https:\/\/www.nichd.nih.gov\/; January 31, 2017. https:\/\/www.nichd.nih.gov\/health\/topics\/preterm."},{"key":"10.1016\/j.vaccine.2023.06.073_b0115","unstructured":"National Institutes of Health. Preeclampsia and Eclampsia. https:\/\/www.nichd.nih.gov\/, January 31, 2017. https:\/\/www.nichd.nih.gov\/health\/topics\/preeclampsia."},{"key":"10.1016\/j.vaccine.2023.06.073_b0120","series-title":"StatPearls. Treasure Island (FL)","article-title":"Acute Postpartum Hemorrhage","author":"Wormer","year":"2022"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.073_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2023.06.073_b0130","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID), Identifier NCT00963430. H1N1 Vaccine in Pregnant Women. ClinicalTrials.gov; Aug. 21, 2009. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00963430 [accessed Jan. 21, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0135","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID) and Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Identifier NCT00992017. Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women. ClinicalTrials.gov; Oct. 08, 2009. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00992017 [accessed Jan. 21, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0140","unstructured":"Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale France and M. C. M. Vaccines B. V. Identifier NCT01024400. Immunogenicity and Safety of an Inactivated Non-adjuvanted A(H1N1)v Influenza Vaccine in Pregnant Women. ClinicalTrials.gov; Dec. 02, 2009. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01024400 [accessed Jan. 20, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0145","unstructured":"Janssen Vaccines, Prevention B.V., Center for Family Health Research, Coalition for Epidemic Preparedness Innovations, and Emory University. Identifier NCT04556526. A Study of a 2-dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in Healthy Pregnant Women. ClinicalTrials.gov; Sep. 21, 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04556526 [accessed Jan. 20, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0150","unstructured":"Janssen Vaccines, Prevention B.V., and Bavarian Nordic GmbH. Identifier NCT02661464. Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and\/or MVA-BN-Filo. ClinicalTrials.gov; Jan. 22, 2016. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02661464 [accessed Jan. 19, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0155","unstructured":"London School of Hygiene and Tropical Medicine et al. Identifier NCT04152486. Effectiveness and Safety of a Heterologous, Two-dose Ebola Vaccine in the DRC. ClinicalTrials.gov; Nov. 05, 2019. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04152486 [accessed Jan. 20, 2020]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0160","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). Identifier NCT00992719. Novartis H1N1 Vaccine in Pregnant Women. ClinicalTrials.gov; Oct. 09, 2009. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00992719 [accessed Jan. 21, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0165","unstructured":"P. Shanghai Institute Of Biological. Identifier NCT01336166. The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine; Apr. 15, 2011. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01336166 [accessed Jan. 18, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0170","unstructured":"Avir Green Hills Biotechnology AG. Identifier NCT01078701. Dose Finding Study of Single Dose GHB11L1 in Healthy Adults. ClinicalTrials.gov; Mar. 02, 2010. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01078701 [accessed Jan. 21, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0175","unstructured":"Epicentre and Medecins Sans Frontieres Netherlands. Identifier NCT03161366. Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine. ClinicalTrials.gov; May 19, 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03161366 [accessed Jan. 21, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0180","unstructured":"GeneOne Life Science Inc, Inovio Pharmaceuticals, and Walter Reed Army Institute of Research. Identifier NCT02670187. Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers. ClinicalTrials.gov; Feb. 01, 2016. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02670187 [accessed Jan. 21, 2021]."},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.073_b0185","doi-asserted-by":"crossref","first-page":"733","DOI":"10.7326\/0003-4819-155-11-201112060-00005","article-title":"Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial","volume":"155","author":"Tsatsaris","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2023.06.073_b0190","unstructured":"GlaxoSmithKline. Identifier NCT00985088. Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older. ClinicalTrials.gov; Sep. 28, 2009. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00985088 [accessed Jan. 21, 2021]."},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.073_b0195","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/infdis\/jir641","article-title":"Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant","volume":"205","author":"Ferguson","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.073_b0200","unstructured":"U.S. Centers for Disease Control and Prevention (CDC). Identifier PACTR201502001037220. STRIVE: Sierra Leone Trial to Introduce a Vaccine against Ebola. Pan African Clinical Trials Registry; Feb. 16, 2015. https:\/\/pactr.samrc.ac.za\/TrialDisplay.aspx?TrialID=1037 [accessed Jan. 21, 2021]."},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.073_b0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3201\/eid2603.191018","article-title":"Pregnancy outcomes among women receiving rVSV\u0394-ZEBOV-GP Ebola vaccine during the sierra leone trial to introduce a vaccine against Ebola","volume":"26","author":"Legardy-Williams","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.073_b0210","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ajog.2012.07.001","article-title":"Immunogenicity and efficacy of influenza immunization during pregnancy: recent and ongoing studies","volume":"207","author":"Adegbola","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.073_b0215","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/cid\/cit057","article-title":"Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women","volume":"56","author":"Abzug","year":"2013","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.073_b0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.vaccine.2016.12.012","article-title":"Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies","volume":"35","author":"Mertz","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.073_b0225","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1471-0528.2003.03008.x","article-title":"Severe acute respiratory syndrome and pregnancy","volume":"110","author":"Wong","year":"2003","journal-title":"Bjog"},{"issue":"15","key":"10.1016\/j.vaccine.2023.06.073_b0230","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2023.06.073_b0235","unstructured":"Centers for Disease Control and Prevention (CDC). Maternal and Infant Outcomes Among Severely Ill Pregnant and Postpartum Women with 2009 Pandemic Influenza A (H1N1) \\mathord{-} - United States, April 2009\\mathord{-} August 2010. MMWR Morb Mortal Wkly Rep 2011;60(35):1193\u20131196."},{"issue":"4","key":"10.1016\/j.vaccine.2023.06.073_b0240","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/AOG.0b013e3181bb44bb","article-title":"H1N1 influenza in pregnancy: cause for concern","volume":"114","author":"Saleeby","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.073_b0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdra.23558","article-title":"Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes","volume":"109","author":"Bebell","year":"2017","journal-title":"Birth Defects Res"},{"issue":"20","key":"10.1016\/j.vaccine.2023.06.073_b0250","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects \u2014 reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.06.073_b0255","unstructured":"WHO. Zika situation report. WHO; Mar. 10, 2017. http:\/\/www.who.int\/emergencies\/zika-virus\/situation-report\/10-march-2017\/en\/ [accessed Feb. 22, 2021]."},{"issue":"7720","key":"10.1016\/j.vaccine.2023.06.073_b0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2023.06.073_b0265","unstructured":"WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). WHO; 2021. https:\/\/www.who.int\/westernpacific\/health-topics\/middle-east-respiratory-syndrome-coronavirus-mers [accessed Feb. 22, 2021]."},{"issue":"7","key":"10.1016\/j.vaccine.2023.06.073_b0270","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciw412","article-title":"Middle east respiratory syndrome coronavirus infection during pregnancy: a report of 5 cases from Saudi Arabia","volume":"63","author":"Assiri","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.073_b0275","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1437-y","article-title":"Impact of Middle East Respiratory Syndrome coronavirus (MERS-CoV) on pregnancy and perinatal outcome","volume":"16","author":"Alserehi","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.073_b0280","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/infdis\/jiu068","article-title":"Stillbirth during infection with middle east respiratory syndrome coronavirus","volume":"209","author":"Payne","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2023.06.073_b0285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3201\/eid2203.151049","article-title":"Middle east respiratory syndrome coronavirus during pregnancy, Abu Dhabi, United Arab Emirates, 2013","volume":"22","author":"Malik","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.06.073_b0290","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID). Identifier NCT03110770. VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents. ClinicalTrials.gov; Apr. 12, 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03110770 [accessed Jan. 21, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0295","article-title":"Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis","volume":"370","author":"Allotey","year":"2020","journal-title":"BMJ"},{"issue":"44","key":"10.1016\/j.vaccine.2023.06.073_b0300","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.15585\/mmwr.mm6944e3","article-title":"Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-October 3, 2020","volume":"69","author":"Zambrano","year":"2020","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2023.06.073_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.12.1197","article-title":"Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: analysis of the Mexican National Surveillance Program","author":"Martinez-Portilla","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.06.073_b0310","unstructured":"Clinical Trials Arena. Moderna starts dosing in Phase II Covid-19 vaccine trial. Clinical Trials Arena; Jun. 01, 2020. https:\/\/www.clinicaltrialsarena.com\/news\/moderna-phaseii-vaccine-trial\/ [accessed Apr. 10, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0315","unstructured":"Pfizer. Pfizer and BioNTech Choose Lead mRNA Vaccine Candidate Against COVID-19 and Commence Pivotal Phase 2\/3 Global Study | pfpfizeruscom. Pfizer; Jul. 27, 2020. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-choose-lead-mrna-vaccine-candidate-0 [accessed Apr. 10, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0320","unstructured":"Erman Michael JS. Pfizer, BioNTech start testing COVID-19 vaccine in pregnant women. Reuters; Feb. 18, 2021. Available: https:\/\/www.reuters.com\/article\/us-health-coronavirus-vaccine-pregnancy-idUSKBN2AI2NT [accessed: Apr. 10, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0325","article-title":"Pfizer\/BioNTech vaccine: UK becomes first country to authorize the Covid-19 vaccine, first shots roll out next week - CNN","author":"Reynolds","year":"2020","journal-title":"CNN"},{"key":"10.1016\/j.vaccine.2023.06.073_b0330","article-title":"COVID-19 vaccine response in pregnant and lactating women: a cohort study","author":"Gray","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.06.073_b0335","unstructured":"CDC. New CDC Data: COVID-19 Vaccination Safe for Pregnant People. CDC Newsroom; Jan. 01, 2016. https:\/\/www.cdc.gov\/media\/releases\/2021\/s0811-vaccine-safe-pregnant.html [accessed Oct. 03, 2021]."},{"key":"10.1016\/j.vaccine.2023.06.073_b0340","unstructured":"CDC. COVID Data Tracker. COVID-19 vaccination among pregnant people aged 18-49 years overall, by race\/ethnicity, and date reported to CDC; Oct. 09, 2021. https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccinations-pregnant-women [accessed Oct. 17, 2021]."},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.073_b0345","first-page":"49","article-title":"Research ethics governance in times of Ebola","volume":"10","author":"Schopper","year":"2017","journal-title":"Public Health Ethics"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.073_b0350","article-title":"Community involvement in biomedical research conducted in the global health context; what can be done to make it really matter?","volume":"19","author":"Fregonese","year":"2018","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.vaccine.2023.06.073_b0355","doi-asserted-by":"crossref","unstructured":"Frew Paula, Saint-Victor DS, Isaacs Margaret Brewinski, Kim Sonnie, Swamy Geeta K, Sheffield Jeanne S et al. Recruitment and Retention of Pregnant Women Into Clinical Research Trials: An Overview of Challenges, Facilitators, and Best Practices | Clinical Infectious Diseases | Oxford Academic. Accessed May 2, 2023. https:\/\/academic.oup.com\/cid\/article\/59\/suppl_7\/S400\/442209#97961248.","DOI":"10.1093\/cid\/ciu726"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23007764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:29:15Z","timestamp":1759404555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23007764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":71,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0264410X23007764"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exclusion of pregnant people from emergency vaccine clinical trials: A systematic review of clinical trial protocols and reporting from 2009 to 2019","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}